» Articles » PMID: 23264848

CtBP2 Promotes Human Cancer Cell Migration by Transcriptional Activation of Tiam1

Overview
Journal Genes Cancer
Specialty Oncology
Date 2012 Dec 25
PMID 23264848
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

The mammalian COOH-terminal binding proteins (CtBPs) CtBP1 and CtBP2 are metabolically regulated transcriptional co-repressors that are degraded upon acute exposure to the alternative reading frame (ARF) tumor suppressor. We reported previously that CtBP stimulates cell migration in certain contexts via repression of PTEN transcription and activation of the phosphatidylinositol 3-kinase (PI3K) pathway. We have now identified an additional and direct mechanism for CtBP stimulation of cell migration via regulation of T-cell lymphoma invasion and metastasis 1 (Tiam1) protein. Tiam1 is a guanine nucleotide exchange factor (GEF) for Rac GTPase that plays a critical role in regulating cell adhesion, invasion, and migration and has been directly implicated in the promotion of cancer progression and metastasis. We noted a strict positive correlation between CtBP2 and Tiam1 expression levels and that CtBP promotion of cell migration required CtBP-dependent transcriptional activation of Tiam1. RNA interference (RNAi)-mediated knockdown of CtBP2 in human colon or lung carcinoma cells led to decreased Tiam1 protein and mRNA expression, while overexpression of CtBP2 increased Tiam1 expression levels. RNAi and overexpression studies also demonstrated that Tiam1 is a key downstream mediator of CtBP2-mediated cell migration. An analysis of the Tiam1 promoter revealed binding sites for the CtBP-interacting Kruppel-like factor 8 (KLF8), and a Tiam1 promoter luciferase reporter was induced in the presence of both KLF8 and CtBP2, consistent with KLF8-dependent CtBP transactivation of Tiam1. Chromatin immunoprecipitation analyses demonstrated CtBP2 occupancy of the Tiam1 promoter that was dependent on the presence of KLF8. Our results indicate that Tiam1 is a transcriptional activation target of CtBP2 and that this interaction promotes the pro-oncogenic function of CtBP2 leading to cancer cell migration. Transcriptional activation thus plays a role in CtBP pro-oncogenic functions along with the previously characterized CtBP co-repressor function.

Citing Articles

Bcl-xL is translocated to the nucleus via CtBP2 to epigenetically promote metastasis.

Zhang T, Li S, Tan Y, Chen X, Zhang C, Chen Z Cancer Lett. 2024; 604:217240.

PMID: 39265800 PMC: 11471366. DOI: 10.1016/j.canlet.2024.217240.


A regulatory role for the unstructured C-terminal domain of the CtBP transcriptional corepressor.

Raicu A, Suresh M, Arnosti D J Biol Chem. 2023; 300(1):105490.

PMID: 38000659 PMC: 10788531. DOI: 10.1016/j.jbc.2023.105490.


Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma.

Chougoni K, Park H, Damle P, Mason T, Cheng B, Dcona M Oncogenesis. 2023; 12(1):53.

PMID: 37949862 PMC: 10638350. DOI: 10.1038/s41389-023-00498-8.


Relationship between cancer stem cell-related SNPs and survival outcomes in patients with primary lung cancer.

Xu X, Liu Y, Hu H, Wang J, Cai Y, Xie J World J Surg Oncol. 2023; 21(1):243.

PMID: 37563730 PMC: 10416443. DOI: 10.1186/s12957-023-03064-z.


A regulatory role for the unstructured C-terminal domain of the CtBP transcriptional corepressor.

Raicu A, Suresh M, Arnosti D bioRxiv. 2023; .

PMID: 37292674 PMC: 10245716. DOI: 10.1101/2023.05.19.541472.


References
1.
Chinnadurai G . The transcriptional corepressor CtBP: a foe of multiple tumor suppressors. Cancer Res. 2009; 69(3):731-4. PMC: 4367538. DOI: 10.1158/0008-5472.CAN-08-3349. View

2.
Minard M, Herynk M, Collard J, Gallick G . The guanine nucleotide exchange factor Tiam1 increases colon carcinoma growth at metastatic sites in an orthotopic nude mouse model. Oncogene. 2005; 24(15):2568-73. DOI: 10.1038/sj.onc.1208503. View

3.
Minard M, Kim L, Price J, Gallick G . The role of the guanine nucleotide exchange factor Tiam1 in cellular migration, invasion, adhesion and tumor progression. Breast Cancer Res Treat. 2004; 84(1):21-32. DOI: 10.1023/B:BREA.0000018421.31632.e6. View

4.
Chen Y, Paliwal S, Draheim K, Grossman S, Lewis B . p19Arf inhibits the invasion of hepatocellular carcinoma cells by binding to C-terminal binding protein. Cancer Res. 2008; 68(2):476-82. PMC: 2376045. DOI: 10.1158/0008-5472.CAN-07-1960. View

5.
Vigil D, Cherfils J, Rossman K, Der C . Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?. Nat Rev Cancer. 2010; 10(12):842-57. PMC: 3124093. DOI: 10.1038/nrc2960. View